findmyKOL

Allen Ho, MD

Enriched profile

Co-Director, Retina Service and Director, Retina Research, Wills Eye Hospital; Professor of Ophthalmology, Sidney Kimmel Medical College of Thomas Jefferson University · Wills Eye Hospital

ORCIDNPI
Region🇺🇸 Plymouth Meeting, PA · Northeast · United StatesSpecialtyOphthalmologyFocusRetinal Diseases and Treatments+4
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2022Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Allen Ho is Co-Director, Retina Service and Director, Retina Research, Wills Eye Hospital; Professor of Ophthalmology, Sidney Kimmel Medical College of Thomas Jefferson University at Wills Eye Hospital. OpenAlex indexes 419 publications with 19,340 citations (h-index 65); ClinicalTrials.gov lists 9 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Ophthalmology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Allen Ho, MD, is Co-Director, Retina Service and Director, Retina Research, Wills Eye Hospital. The public record shows 419 publications with 19,340 citations (h-index 65), centered on Retinal Diseases and Treatments, Retinal and Macular Surgery, Retinal and Optic Conditions. It also documents an investigator role on 9 registered clinical trials, industry payments reported by 24 companies.

  • Most recent indexed publication: 2022 · Nature medicine
  • Top research focus: Retinal Diseases and Treatments
  • 9 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 24 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Macular Degeneration (AMD)2 trialsEpiretinal Membrane2 trialsChoroidal Neovascularization1 trialCentral Serous Chorioretinopathy1 trialRetinal Detachment1 trialPapillary Thyroid Microcarcinoma1 trialEdema1 trialMacular Edema1 trialRetinal Vein Occlusion1 trial

Research focus

OpenAlex concept fingerprint
Retinal Diseases and TreatmentsRetinal and Macular SurgeryRetinal and Optic ConditionsRetinal Imaging and AnalysisOcular Diseases and Behçet’s Syndrome

Drugs & molecules

across trials, industry payments and publications
Eyleageneric · AfliberceptClinical trialsIndustry payments32Publications2Lucentisgeneric · RanibizumabClinical trialsIndustry payments8Publications3Dextenzageneric · DexamethasoneClinical trialsIndustry payments19Publications

Works with

trial sponsors and companies reporting payments
Regeneron Pharmaceuticals, Inc.Clinical trialsIndustry payments27Alcon Research LLCClinical trialsIndustry payments16Alcon Vision LLCClinical trialsIndustry payments16

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
419publications

Distinct works indexed by OpenAlex, matched via ORCID; 2 in PubMed.

19,340citations

Total citations across indexed works.

65h-index

Hirsch index (OpenAlex). i10-index 200.

Clinical & industry

trials, payments and federal funding
9clinical trials

Investigator role on registered studies.

View trials
24companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

24 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    67.3%
    Antineovascularisation agents65.8%
    Faricimab-svoa100%
    Part B, office-administered42 patients
    Corticosteroid0.8%
    Prednisolone Acetate100%
    Part D91 patients
  • Cancer & immunology

    31.6%
    Vascular Endothelial Growth Factor Inhibitor19.3%
    Aflibercept100%
    Part B, office-administered377 patients
    Complement Inhibitor12.3%
    Pegcetacoplan100%
    Part B, office-administered34 patients
  • Musculoskeletal

    0.8%
    Cyclooxygenase Inhibitor0.8%
    Ketorolac Tromethamine100%
    Part D53 patients
3 more therapeutic areas behind the reveal.Reveal →
Where care is delivered (Part B)0.1% facility · 99.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Congress activity

Updated 27 Aug 2026

1 congress contribution (2025) across ASTRO per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 27 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/allen-ho-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com

Mentions by others

where others cite or feature them
  • Facebook

    facebook.com/willseyehospital/photos/last-week-dr-allen-ho-md-facs-fasrs-co-director-of-the-wills-eye-retina-service-/953256286807973

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com
  • Instagram

    instagram.com/wills_eye/p/CP3Wc9CLsiQ

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com
  • Other

    asrs.org/find-a-specialist/profile/12/Allen-C-Ho

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org
1 more mention behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Retina Fellowship

    Manhattan Eye, Ear & Throat Hospital

    1994
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →willseye.org
  • Board Certified

    American Board of Ophthalmology

    1993
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →willseye.org
  • MD

    Columbia University College of Physicians and Surgeons

    1988
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →willseye.org
  • BA

    Cornell University

    1984
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →willseye.org

Editorial & leadership roles

journal and society appointments
  • Past President

    The Retina Society

    2021
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →retinasociety.org
  • Chief Medical Editor

    Retina Today

    2008
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →retinatoday.com
  • Editor-in-Chief

    Current Opinion in Ophthalmology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →willseye.org
5 more roles behind the reveal.Reveal →

Awards & honors

honors on the public record
7 more awards behind the reveal.Reveal →

Secondary affiliations

appointments beyond the home institution
1 more affiliation behind the reveal.Reveal →

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.